BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 26715845)

  • 1. Frequency and risk factors of COPD exacerbations and hospitalizations: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study).
    Alexopoulos EC; Malli F; Mitsiki E; Bania EG; Varounis C; Gourgoulianis KI
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2665-74. PubMed ID: 26715845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.
    Mitsiki E; Bania E; Varounis C; Gourgoulianis KI; Alexopoulos EC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1371-82. PubMed ID: 26229456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex discrepancies in COPD patients and burden of the disease in females: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study).
    Papaioannou AI; Bania E; Alexopoulos EC; Mitsiki E; Malli F; Gourgoulianis KI
    Int J Chron Obstruct Pulmon Dis; 2014; 9():203-13. PubMed ID: 24600217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.
    Negewo NA; Gibson PG; Wark PA; Simpson JL; McDonald VM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2929-2942. PubMed ID: 29062230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
    Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
    Ágh T; Inotai A; Mészáros Á
    Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
    Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
    PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to inhalers and comorbidities in COPD patients. A cross-sectional primary care study from Greece.
    Ierodiakonou D; Sifaki-Pistolla D; Kampouraki M; Poulorinakis I; Papadokostakis P; Gialamas I; Athanasiou P; Bempi V; Lampraki I; Tsiligianni I;
    BMC Pulm Med; 2020 Sep; 20(1):253. PubMed ID: 32977779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical activity and the frequency of acute exacerbations in patients with chronic obstructive pulmonary disease.
    Schönmann M; Sievi NA; Clarenbach CF; Brack T; Brutsche M; Frey M; Irani S; Leuppi JD; Ruediger J; Senn O; Thurnheer R; Kohler M
    Lung; 2015 Feb; 193(1):63-70. PubMed ID: 25503750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study.
    Tzanakis N; Koulouris N; Dimakou K; Gourgoulianis K; Kosmas E; Chasapidou G; Konstantinidis A; Kyriakopoulos C; Kontakiotis T; Rapti A; Gaga M; Kalafatakis K; Kostikas K
    BMC Pulm Med; 2021 Jul; 21(1):216. PubMed ID: 34243744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
    Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
    Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
    Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.
    Johansson G; Mushnikov V; Bäckström T; Engström A; Khalid JM; Wall J; Hoti F
    BMC Pulm Med; 2018 Jan; 18(1):17. PubMed ID: 29370846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of multidisciplinary care in chronic obstructive pulmonary disease patients at the Central Chest Institute of Thailand.
    Panjapornpon K; Tanont S
    J Med Assoc Thai; 2012 Aug; 95 Suppl 8():S24-30. PubMed ID: 23130471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
    Foda HD; Brehm A; Goldsteen K; Edelman NH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD exacerbation frequency and its association with health care resource utilization and costs.
    Dhamane AD; Moretz C; Zhou Y; Burslem K; Saverno K; Jain G; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2609-18. PubMed ID: 26664109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
    Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.